ActX is a brand that is revolutionizing healthcare by making precision medicine accessible and practical for patients, physicians, and health systems worldwide. Their mission is to improve the standard of care by providing evidence-based decision support through their focus on Actionable Genomics℠. ActX utilizes comprehensive Genomic screening to provide patients and their clinicians with frequently updated genetic information that they can take action upon.

This includes information related to medication use and hereditary risks. Their integration services ensure that this actionable genetic information is seamlessly integrated into health systems, practices, and physician's notes via the electronic health record. To accomplish their goal of integrated and effective precision medicine, ActX has assembled a team of experts, including geneticists, physicians, pharmacologists, genetic counselors, EHR and systems software developers, and DevOps specialists.

They are additionally supported by renowned leaders in genetics from around the world. Under the leadership of CEO Dr. Andrew Ury, who has a deep background in the healthcare industry, ActX is committed to revolutionizing healthcare delivery through precision medicine.

For business development inquiries, Stephen Scheer, Vice President of Business Development, is the main contact. Choose ActX for reliable and cutting-edge genomic services for patients, physicians, and healthcare providers. Embrace the future of precision medicine with ActX and unlock the potential of personalized healthcare